Ani Pharmaceuticals (ANIP) Asset Utilization Ratio (2011 - 2026)
Ani Pharmaceuticals (ANIP) posted Asset Utilization Ratio of 0.65 for Q1 2026, up 4.06% sequentially from 0.62 in Q4 2025, and up 23.37% YoY from 0.52 in Q1 2025.
Ani Pharmaceuticals (ANIP) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Asset Utilization Ratio for 16 years, with the latest figure at 0.65 in Q1 2026.
- Quarterly Asset Utilization Ratio rose 23.37% year-over-year to 0.65 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.65 (up 23.37% YoY) and the FY2025 annual result came in at 0.65, up 15.5% from the prior year.
- Asset Utilization Ratio grew to 0.65 in Q1 2026 per ANIP's latest filing, from 0.62 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.65 in Q1 2026 and troughed at 0.3 in Q1 2022.
- A 5-year average of 0.5 and a median of 0.51 in 2023 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2022 and 2023: Asset Utilization Ratio declined 18.83% in 2022, then soared 57.73% in 2023.
- Over 5 years, Asset Utilization Ratio stood at 0.42 in 2022, then rose by 28.56% to 0.54 in 2023, then dropped by 11.95% to 0.48 in 2024, then grew by 29.82% to 0.62 in 2025, then advanced by 4.06% to 0.65 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.65, 0.62, and 0.6 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.64 Bn | 1.28 Bn | 165.89 Mn | 0.67 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.67 |
| Mar 31, 2026 | 0.65 |
| Dec 31, 2025 | 0.62 |
| Sep 30, 2025 | 0.60 |
| Jun 30, 2025 | 0.57 |
| Mar 31, 2025 | 0.52 |
| Dec 31, 2024 | 0.48 |
| Sep 30, 2024 | 0.50 |
| Jun 30, 2024 | 0.59 |
| Mar 31, 2024 | 0.57 |
| Dec 31, 2023 | 0.54 |
| Sep 30, 2023 | 0.51 |
| Jun 30, 2023 | 0.49 |
| Mar 31, 2023 | 0.47 |
| Dec 31, 2022 | 0.42 |
| Sep 30, 2022 | 0.38 |
| Jun 30, 2022 | 0.34 |
| Mar 31, 2022 | 0.30 |
| Dec 31, 2021 | 0.28 |
| Sep 30, 2021 | 0.36 |